Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With Myelofibrosis

Clinical trial NCT01732445 · COMPLETED

Trial details

NCT number: NCT01732445
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anemia Primary Myelofibrosis Secondary Myelofibrosis

Start date: 2013-04-01
Primary completion: 2016-07-14
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.